We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

14 hedge funds and large institutions have $13.6M invested in Tenax Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $7.32M → $13.6M (+$6.33M)

0% more ownership

Funds ownership: 0.01% → 0.02% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

7% less funds holding

Funds holding: 15 → 14 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GG
Gofen & Glossberg
Illinois
+$6.25M
2
IC
Ikarian Capital
Texas
+$762K
3
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$115K
4
BFM
Boothbay Fund Management
New York
+$75.9K
5
OCA
Octagon Capital Advisors
New York
+$49.7K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$147K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$113K
3
Morgan Stanley
Morgan Stanley
New York
-$62.8K
4
Ameriprise
Ameriprise
Minnesota
-$62K
5
Citadel Advisors
Citadel Advisors
Florida
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
1
Gofen & Glossberg
Illinois
$6.76M +$6.25M +2,387 New
AC
2
Armistice Capital
New York
$3.58M – – –
BlackRock
3
BlackRock
New York
$906K – – –
IC
4
Ikarian Capital
Texas
$826K +$762K +291 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$642K +$10.5K +4 +2%
State Street
6
State Street
Massachusetts
$241K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$182K -$147K -56 -47%
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$124K +$115K +44 New
FWP
9
FAS Wealth Partners
Kansas
$103K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$90K – – –
BFM
11
Boothbay Fund Management
New York
$82K +$75.9K +29 New
Northern Trust
12
Northern Trust
Illinois
$61K – – –
OCA
13
Octagon Capital Advisors
New York
$54K +$49.7K +19 New
BCV
14
Banque Cantonale Vaudoise
Switzerland
$2K – – –
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
– -$113K -32 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$62.8K -24 Closed
Ameriprise
17
Ameriprise
Minnesota
– -$62K -19 Closed
Citadel Advisors
18
Citadel Advisors
Florida
– -$44K -13 Closed
TRCT
19
Tower Research Capital (TRC)
New York
– -$2.62K -1 Closed
UBS Group
20
UBS Group
Switzerland
– -$2.62K -1 Closed

TENX Hedge Fund Activity: Q3 2021 in Review

14 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2021, worth a combined $13.6M — up 86% from $7.32M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TENX and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Gofen & Glossberg, opening a new position worth an estimated $6.25M. The largest seller was Renaissance Technologies, cutting an estimated $147K.

  • 14 institutional investors held Tenax Therapeutics (TENX) as of Q3 2021, down from 15 in Q2 2021.
  • Funds reported $13.6M of Tenax Therapeutics stock for Q3 2021, up 86% quarter-over-quarter.
  • 5 funds opened new Tenax Therapeutics positions in Q3 2021 and 6 closed out, a net change of -1 holder.
  • The largest Tenax Therapeutics buyer in Q3 2021 was Gofen & Glossberg, an estimated $6.25M added.
  • The largest Tenax Therapeutics seller in Q3 2021 was Renaissance Technologies, an estimated $147K sold.

Based on aggregated 13F filings for Q3 2021.